Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,851Revenue $M939Net Margin (%)3.8Z-Score3.1
Enterprise Value $M2,096EPS $0.7Operating Margin %5.0F-Score5
P/E(ttm))52.7Cash Flow Per Share $2.6Pre-tax Margin (%)3.9Higher ROA y-yN
Price/Book2.210-y EBITDA Growth Rate %3.6Quick Ratio2.0Cash flow > EarningsY
Price/Sales2.05-y EBITDA Growth Rate %-2.3Current Ratio2.9Lower Leverage y-yY
Price/Cash Flow15.8y-y EBITDA Growth Rate %4.3ROA % (ttm)2.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)4.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M52.1ROI % (ttm)2.1Gross Margin Increase y-yY

Gurus Latest Trades with HAE

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HAEJames Barrow 2014-03-31 Add0.1%$31.84 - $43.37
($38.44)
$ 35.48-8%Add 217.54%3,042,669
HAEJoel Greenblatt 2014-03-31 Buy 0.02%$31.84 - $43.37
($38.44)
$ 35.48-8%New holding, 42809 sh.42,809
HAEJames Barrow 2013-12-31 Buy 0.06%$38.87 - $43.83
($41.15)
$ 35.48-14%New holding, 958209 sh.958,209
HAEMeridian Funds 2012-12-31 Add0.29%$38.92 - $41.38
($40.27)
$ 35.48-12%Add 100%354,600
HAEJean-Marie Eveillard 2012-12-31 Add$38.92 - $41.38
($40.27)
$ 35.48-12%Add 100%8,000
HAEMeridian Funds 2012-09-30 Add0.09%$68.61 - $81.4
($74.4)
$ 35.48-52%Add 21.86%177,300
HAEMeridian Funds 2012-06-30 Buy 0.36%$66.79 - $73.87
($69.93)
$ 35.48-49%New holding, 145500 sh.145,500
HAEJoel Greenblatt 2012-03-31 Sold Out -0.12%$61.85 - $70.45
($62.3)
$ 35.48-43%Sold Out0
HAEJoel Greenblatt 2011-09-30 Add0.05%$56.03 - $69.18
($62.23)
$ 35.48-43%Add 77.59%13,062
HAEGeorge Soros 2011-09-30 Sold Out -0.0046%$56.03 - $69.18
($62.23)
$ 35.48-43%Sold Out0
HAEJoel Greenblatt 2011-06-30 Reduce-0.04%$62.42 - $70.2
($66.26)
$ 35.48-46%Reduce -21.71%7,355
HAEJoel Greenblatt 2011-03-31 Buy 0.18%$58.18 - $65.06
($61.09)
$ 35.48-42%New holding, 9395 sh.9,395
HAEGeorge Soros 2010-12-31 Buy $54.62 - $64.38
($59.02)
$ 35.48-40%New holding, 4900 sh.4,900
HAEJean-Marie Eveillard 2010-06-30 Reduce$53.06 - $60.62
($55.99)
$ 35.48-37%Reduce -60%4,000
HAEJean-Marie Eveillard 2007-09-30 Buy $47.88 - $53.16
($50.2)
$ 35.48-29%New holding, 10000 sh.10,000
HAEGeorge Soros 2006-12-31 Sold Out -0.37%$44.3 - $48.91
($45.9)
$ 35.48-23%Sold Out0
HAEGeorge Soros 2006-09-30 Add0.26%$41.85 - $47.57
($45.8)
$ 35.48-22%Add 250%140,000
HAEGeorge Soros 2006-06-30 Buy 0.25%$46.5 - $54.9
($50.6)
$ 35.48-30%New holding, 40000 sh.40,000
HAEMeridian Funds 2004-12-31 Sold Out $31.97 - $36.99
($35)
$ 35.481%eliminated -- 791 000 sh.0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HAE is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
HAE Joel Greenblatt 2014-03-3142,8090.080.02New Buy
HAE James Barrow 2014-03-313,042,6695.850.14+217.54%
HAE Jean-Marie Eveillard 2014-03-3110,0000.020
HAE Meridian Funds 2013-06-30439,5000.840.68+12.55%
Premium Most recent portfolio changes are included for Premium Members only!


HAE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GRANADILLO PEDRO PDirector 2014-07-07Sell5,837$35.97-1.36view
CONCANNON BRIANPresident & CEO 2014-07-01Sell4,600$35.83-0.98view
GELBMAN RONALD GDirector 2014-06-12Sell9,184$344.35view
BEST LAWRENCE CDirector 2014-06-12Sell9,184$33.914.63view
GRANADILLO PEDRO PDirector 2014-06-06Sell5,837$34.692.28view
CONCANNON BRIANPresident & CEO 2014-06-02Sell4,600$33.545.78view
FOOTE SUSAN BARTLETTDirector 2014-05-12Sell9,184$33.167view
GRANADILLO PEDRO PDirector 2014-05-07Sell5,837$31.1413.94view
CONCANNON BRIANPresident & CEO 2014-05-01Sell4,600$30.0118.23view
ALLEN PETER MPresident, Global Plasma 2014-04-28Sell30,000$30.715.57view

Press Releases about HAE :

    Quarterly/Annual Reports about HAE:

    News about HAE:

    Articles On GuruFocus.com
    Guru Held Stocks Near Historical Low P/B Jul 22 2014 
    The Olstein All Cap Value Fund’s 2014 First Quarter Letter to Shareholders Jul 22 2014 
    This Blood Management Company Can Be A Safe Investment Jul 13 2014 
    Meridian Funds Comments on Haemonetics Aug 28 2013 
    Meridian Funds' Second Quarter 2013 Commentary Aug 28 2013 
    Weeky CFO Sells Highlight: ADBE, HAE, WAGE, OVTI, ICPT Jun 24 2013 
    Allscripts-Misys Reports 5 Insider Buys the Day Before Barclays Conference Mar 13 2013 
    Weekly Guru Bargains Highlights: HAE, DLTR, QCOR, MTX, AMD Jan 21 2013 
    Weekly Guru Bargains Highlights: CIG, ARO, NKE, DLTR, HAE Jan 13 2013 
    Weekly Guru Bargains Highlights: FTNT, VVUS, HAE, PC, TIBX Dec 09 2012 

    More From Other Websites
    Charles J. Dockendorff Joins Haemonetics Board of Directors Jul 23 2014
    Charles J. Dockendorff Joins Haemonetics Board of Directors Jul 23 2014
    HAEMONETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Jul 07 2014
    Haemonetics (HAE) is in Overbought Territory: What's Next? Jun 30 2014
    Haemonetics Sets Date for First Quarter Fiscal Year 2015 Earnings Release: July 30, 2014 Jun 30 2014
    Haemonetics Suffers on Dismal Q4, Poor FY15 Outlook Jun 27 2014
    HAEMONETICS CORP Financials May 29 2014
    Haemonetics to Present at the William Blair & Company Growth Stock Conference May 28 2014
    Haemonetics to Present at The Goldman Sachs 35th Annual Global Healthcare Conference May 27 2014
    Haemonetics to Present at The Jefferies 2014 Global Healthcare Conference May 23 2014
    Cloud Buys: Big Swing Trade Ideas for Friday, May 23 May 23 2014
    HAEMONETICS CORP Files SEC form 10-K, Annual Report May 22 2014
    Will This Price Target Increase Help Haemonetics (HAE) Stock Today? (Update) May 21 2014
    Haemonetics sees FY16 revenue $960M-$975M, consensus $965M May 20 2014
    Haemonetics sees FY15 revenue $920M-$939M , consensus $929.5M May 20 2014
    Haemonetics to host Investor and Analyst Meeting May 16 2014
    Haemonetics sees activities related to VCC 'substantially' complete in FY16 May 01 2014
    HAEMONETICS CORP Files SEC form 8-K, Costs Associated with Exit or Disposal Activities May 01 2014
    Haemonetics Slips on Q4 Earnings and Revs Miss Apr 30 2014
    Kent Davies Joins Haemonetics as President, Global Markets Apr 30 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide